Diffuse Large B-cell Lymphoma - Globe Thesis

Keyword [Diffuse Large B-cell Lymphoma] Result: 161 - 180 \| Page: 9 of 10
161.	Analysis Of Prognostic Factors Of Diffuse Large B-cell Lymphoma
162.	The Clinical Pathological Significances Of C-MYC, BCL2Translocation And EBV, CD5, CD30Expression In Diffuse Large B Cell Lymphoma
163.	Aggressive B Cell Lymphoma In Gastrointestinal Tract:Clinicopathologic Analysis Of54Cases
164.	Analysis Of MYC, BCL2Gene Abnormalities And Clinical Prognosis In Patients With DLBCL Concurrent With Hepatitis B Virus Infection
165.	Clinical Analysis Of 39 Diffuse Large B Cell Lymphoma Cases
166.	Efficacy And Prognosis Of Immunochemotherapy To Diffuse Large B Cell Lymphoma
167.	The Study Of B7-H1/PD-1Pathway In Diffuse Large B Cell Lymphoma
168.	To Study The MicroRNA Expression Profilesinfor AIDS Related Diffuse Large B-cell Lymphoma
169.	Study On C-MYC Protein Expression And Its Significance In Diffuse Large B Cell Liyphoma
170.	Expression Of HIP1R And FOXP1 In Diffuse Large B-Cell Lymphoma And Its Relationship With Prognosis
171.	Analysis Of Predicting Efficiency Of NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma
172.	CD 10, BCL-6, MUM-1 And BCL-2 Expression In Diffuse Large B Cell Lymphoma And Its Relationship With Prognosis
173.	To Investigate The MicroRNA Expression Profile In Diffuse Large B-cell Lymphoma
174.	Prognostic Factors Analysis Of 59 Patients With Diffuse Large B-cell Lymphoma
175.	A Case Report Of Primary Gastric Malignant Lymphoma And Literature Review
176.	Expression And Function Of MicroRNA-29b In Diffuse Large B-cell Lumphoma
177.	Expression And Significance Of IL-12 In Classical Hodgkin Lymphoma And Diffuse Large B-cell Lymphoma
178.	Expression Of Has-miR-339-3p And Has-miR-339-5p In Diffuse Large B_cell Lymphoma And Its Significance
179.	Clinical Pathological Features And Analysis Of 179 Caseswith Diffuse Large B Cell Lymphoma(DLBCL)
180.	Clinical Study Of Young Patients With High Risk Diffuse Large B-Cell Lymphoma(DLBCL)
<<First <Prev Next> Last>> Jump to